Use this URL to cite or link to this record in EThOS: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.659230
Title: Effect of some intranasal formulations used in the management of allergic rhinitis on mucociliary function
Author: Ayoub, Marwa M. R. R.
ISNI:       0000 0004 5359 6119
Awarding Body: University of Brighton
Current Institution: University of Brighton
Date of Award: 2015
Availability of Full Text:
Access through EThOS:
Access through Institution:
Abstract:
In the management of allergic rhinitis, drugs are delivered to the nasal cavity for a local effect. Mucociliary clearance (MC), the airway’s primary innate defense mechanism against inhaled foreign particles, clears the drug formulations and undesirably decreases their residence time. Certain formulation variables are hence designed to optimize the intranasal (IN) residence time. It is therefore important that the effect of IN formulations on MC is understood. MC is attained via ciliary input (cilia length and density and ciliary beat frequency (CBF)) and airway surface liquid (periciliary fluid underlying mucous blanket of optimum amount, depth and viscoelastic properties). In the present study, ovine ex-vivo models were used to investigate the effect of a number of anti-allergic IN formulations, by GlaxoSmithKline (GSK), on different components of MC, namely mucin secretion, CBF and mucociliary transport rate (MTR). In addition, the in-vitro cytotoxic effect of these formulations on the human bronchial epithelial cell line, 16HBE14o-, was examined using an MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium-bromide) viability assay.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.659230  DOI: Not available
Keywords: B200 Pharmacology Toxicology and Pharmacy ; C000 Biological and Biomedical Sciences
Share: